--:--:--LOCAL ·--:--UTC
    US EQUITIESLAST CLOSE
    AAPL$344.63-1.23%
    MSFT$521.91-1.55%
    GOOGL$279.84-1.40%
    AMZN$240.35-1.41%
    NVDA$204.64-4.22%
    META$614.99-1.53%
    TSLA$399.81-0.87%
    NFLX$62.08+0.05%
    BRK.B$542.49+0.10%
    AVGO$326.08-5.48%
    DIS$110.94+0.03%
    SBUX$103.67-1.74%
    MCD$258.12+0.29%
    NKE$38.67+0.65%
    COST$1012.28+1.63%
    WMT$123.51+1.86%
    HD$329.20+0.07%
    KO$94.08+1.36%
    PG$161.57+0.61%
    ORCL$130.67-6.37%
    CRM$229.17-0.75%
    ADBE$250.23+0.85%
    AMD$504.80-10.88%
    INTC$65.76-28.58%
    QCOM$164.79-11.12%
    CSCO$104.51-3.76%
    IBM$257.81-0.18%
    UBER$65.25-0.75%
    ABNB$164.39-1.24%
    SHOP$157.49-5.63%
    PYPL$57.01+0.11%
    COIN$143.54-10.62%
    PLTR$184.11-6.27%
    HOOD$84.99-7.21%
    JPM$337.04-1.90%
    V$413.59+0.74%
    MA$638.01+0.36%
    BAC$50.01-2.21%
    GS$894.55-3.58%
    LLY$1417.54+3.19%
    UNH$406.97-0.96%
    JNJ$273.20-0.73%
    PFE$30.52+1.90%
    XOM$187.25+2.16%
    BA$171.55-0.64%
    BABA$98.04-1.51%
    TSM$406.13-5.95%
    US EQUITIESLAST CLOSE
    AAPL$344.63-1.23%
    MSFT$521.91-1.55%
    GOOGL$279.84-1.40%
    AMZN$240.35-1.41%
    NVDA$204.64-4.22%
    META$614.99-1.53%
    TSLA$399.81-0.87%
    NFLX$62.08+0.05%
    BRK.B$542.49+0.10%
    AVGO$326.08-5.48%
    DIS$110.94+0.03%
    SBUX$103.67-1.74%
    MCD$258.12+0.29%
    NKE$38.67+0.65%
    COST$1012.28+1.63%
    WMT$123.51+1.86%
    HD$329.20+0.07%
    KO$94.08+1.36%
    PG$161.57+0.61%
    ORCL$130.67-6.37%
    CRM$229.17-0.75%
    ADBE$250.23+0.85%
    AMD$504.80-10.88%
    INTC$65.76-28.58%
    QCOM$164.79-11.12%
    CSCO$104.51-3.76%
    IBM$257.81-0.18%
    UBER$65.25-0.75%
    ABNB$164.39-1.24%
    SHOP$157.49-5.63%
    PYPL$57.01+0.11%
    COIN$143.54-10.62%
    PLTR$184.11-6.27%
    HOOD$84.99-7.21%
    JPM$337.04-1.90%
    V$413.59+0.74%
    MA$638.01+0.36%
    BAC$50.01-2.21%
    GS$894.55-3.58%
    LLY$1417.54+3.19%
    UNH$406.97-0.96%
    JNJ$273.20-0.73%
    PFE$30.52+1.90%
    XOM$187.25+2.16%
    BA$171.55-0.64%
    BABA$98.04-1.51%
    TSM$406.13-5.95%
    Plug stock market data into your AI agent — one command: Get your free API key →
    LoginGet API Key
    Company data coverage · ASX

    PYC — PYC THERAPEUTICS LIMITED

    Data coverage, completeness and provenance for PYC THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.

    ASX AUS
    Core-field completeness
    64.7%
    Statement periods
    FY2022–FY2026
    Filings archived
    3 (3 md)
    Price collection time
    2026-11-01 07:22 UTC

    Stored price coverage

    Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.

    Recent stored price bars, without investment interpretation
    DateCloseCurrencySourceAdjustment basis
    2026-10-301.8800AUDyfinanceSplit- and dividend-adjusted close
    2026-10-291.9350AUDyfinanceSplit- and dividend-adjusted close
    2026-10-281.9700AUDyfinanceSplit- and dividend-adjusted close
    2026-10-271.9200AUDyfinanceSplit- and dividend-adjusted close
    2026-10-261.7550AUDyfinanceSplit- and dividend-adjusted close

    GET /api/v1/companies/PYC/prices · Price parameters and adjustment semantics

    Dataset availability · Handle missing data

    Profile

    PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program, which is in Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for treating blinding eye disease named Autosomal Dominant Optic Atrophy, which is in clinical studies; PYC-002, a drug program for the treatment of severe neurodevelopmental disorder named Phelan-McDermid Syndrome, which is in pre-clinical studies; and PYC-003 to treat autosomal dominant polycystic kidney disease, which is in early-stage clinical trials. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

    Website: https://pyctx.com · Profile fields populated: 60%

    Data completeness by statement

    Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/PYC/financials.

    Income statement7/10 fields (70.0%)
    Balance sheet12/14 fields (85.7%)
    Cash flow5/6 fields (83.3%)
    Per-share1/4 fields (25.0%)

    Financial statement coverage (AUD)

    Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

    PeriodPeriod end RevenueNet incomeTotal assetsTotal equity Fields populatedSource
    FY2026 (AUD) 2026-06-30 25 yfinance
    FY2025 (AUD) 2025-06-30 27 yfinance
    FY2024 (AUD) 2024-06-30 27 yfinance
    FY2023 (AUD) 2023-06-30 27 yfinance
    FY2022 (AUD) 2022-06-30 27 yfinance

    Get PYC data via the API

    The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.

    Company profile

    Name, sector, industry, HQ, employees, market cap, source-tagged.

    GET /api/v1/companies/PYC

    Financial statements

    Multi-year statements with per-field source tags and completeness.

    GET /api/v1/companies/PYC/financials

    Computed ratios

    P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

    GET /api/v1/companies/PYC/metrics/summary

    Filings archive

    Report PDFs with LLM-ready markdown conversions where available.

    GET /api/v1/companies/PYC/filings

    News & announcements

    Dated press releases and announcements with source links.

    GET /api/v1/companies/PYC/news

    Quick start

    Create a free key, then:

    curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/PYC

    Query PYC programmatically

    Free tier — instant API key. Built for AI agents.

    Other ASX · Health Care companies covered

    Frequently Asked Questions

    What data does the API provide for PYC?
    Stored coverage for PYC: price data available, financial statements available, 3 archived filings. REST endpoints are under /api/v1/companies/PYC; inspect available source metadata for provenance.
    How complete is PYC's financial data?
    The anchor reporting period (FY2026) has 64.7% of the 17 core statement fields populated. Primary source: yfinance.
    What reporting periods are covered for PYC?
    5 fiscal-year periods are stored (FY2022–FY2026), with per-period field counts and source tags available via /api/v1/companies/PYC/financials.
    Where does PYC's data come from?
    Stored price source: yfinance. Primary source for the statement snapshot: yfinance. Inspect available period and field source tags at /api/v1/companies/PYC/financials; missing tags do not establish provenance.